Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Wednesday, February 12, 2025

Cancer vaccine shows promising results for certain patients

 February 12, 2025     Health, Health News Today on Fox News     No comments   

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine.

Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and other universities have announced early findings from a study of an anti-tumor vaccine for patients with advanced kidney cancer.

"Patients with stage 3 or 4 kidney cancer are at high risk of recurrence," said co-senior author and co-principal investigator Toni Choueiri, MD, director of the Lank Center for Genitourinary Cancer at Dana-Farber, in a press release.

DISEASE STARTS ON YOUR PLATE, CARDIOLOGIST SAYS — HERE'S WHAT TO CHANGE

"The tools we have to lower that risk are not perfect, and we are relentlessly looking for more."

After undergoing surgery to remove a malignant tumor, the study’s nine participants received a cancer vaccine that was intended to "train" their immune systems to identify and attack any lingering cancer cells, according to the press release.

Each vaccine was personalized to match the individual patient’s tumor type based on cancer cells that were removed during surgery. These cells contain "neoantigens," which are "tiny fragments of mutant proteins," the release stated. The researchers used "predictive algorithms" to determine which neoantigens should be included in the vaccine to provide the highest level of immunity. 

PROSTATE CANCER CASES SPIKE IN THIS US STATE AS DOCTORS SHARE LIKELY REASON

Five of the patients also received ipilimumab, a type of immunotherapy drug.

All nine patients showed a "successful anti-cancer immune response" after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.

Within three weeks of receiving the vaccine, patients showed an "immune response," with T-cells spiking by more than 166 times, the release said. (T-cells, also known as T lymphocytes, are immune cells that help to fight cancer and prevent infection.)

In the study, the T cells were found to remain in the patient’s body for up to three years and attacked the existing tumor cells.

"We observed a rapid, substantial, and durable expansion of new T cell clones related to the vaccine," said Patrick Ott, MD, PhD, director of the Center for Cancer Vaccines at Dana-Farber.

"These results support the feasibility of creating a highly immunogenic personalized neoantigen vaccine in a lower mutation burden tumor and are encouraging, though larger-scale studies will be required to fully understand the clinical efficacy of this approach."

The results of the clinical trial were reported in the journal Nature on Feb. 5. 

"We’re very excited about these results, which show such a positive response in all nine patients with kidney cancer," Choueiri noted.

For most stage 3 or 4 kidney cancer patients, the standard treatment is surgical removal of the tumor, which is often followed by an immunotherapy drug called Pembrolizumab (Keytruda).

COMMON CANCER TYPE COULD BE DETECTED WITH NEW BLOOD TEST

"Pembrolizumab induces an immune response that reduces the risk of the cancer coming back," according to Dana-Farber. "However, about two-thirds of patients can still recur and have limited treatment options."

First author David A. Braun, MD, PhD, a medical oncologist and physician-scientist at Yale Cancer Center and Yale School of Medicine, noted that the approach used in this study was "truly distinct from vaccine attempts in kidney cancer."

"We pick targets that are unique to the cancer and different from any normal part of the body, so the immune system can be effectively 'steered' toward the cancer in a very specific way," Braun said in the release. 

"We learned which specific targets in the cancer are most susceptible to immune attack and demonstrated that this approach can generate long-lasting immune responses, directing the immune system to recognize cancer. We believe this work can form a foundation for the development of neoantigen vaccines in kidney cancer."

Charles Nguyen, MD, a medical oncologist who specializes in kidney cancer at City of Hope in Orange County, California, noted that kidney cancer is among the 10 most common cancers among men and women in the U.S. 

"Patients with early stage (localized) kidney cancer are often first treated with surgery to remove the tumor — however, many patients have a risk of the cancer coming back years after surgery, and there is a great interest in finding ways to lower the risk of cancer recurrence," Nguyen, who was not involved in the study, told Fox News Digital.

"This exciting clinical trial evaluated a personalized cancer vaccine that uses genetic information from each patient's cancer to train and enhance the patient's immune system to recognize the cancer and prevent it from recurring." 

While Nguyen acknowledged that this was a small study, all nine patients who received the vaccine were cancer-free even three years later. 

"This is a very exciting and promising tool for many of our patients with kidney cancer, where we can one day make a cure possible for all."

Some patients did experience side effects from the vaccine, including local reactions at the vaccine injection site and flu-like symptoms, although "no higher-grade side effects were reported."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The researchers also acknowledged that there were some limitations associated with the study.

"There were limitations in the antigen-prediction tools available at the time and in the ability to target only a single antigen," they wrote.

"Moreover, it was conducted in the setting of active metastatic disease in a number of study participants."

Future research with larger clinical trials are planned to confirm the vaccine's effectiveness and full potential, the release stated. 

For more Health articles, visit www.foxnews.com/health

Funding for this study was provided by the Gateway for Cancer Research, the U.S. Department of Defense, Yale Cancer Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School, Trust Family Foundation, Michael Brigham, Pan-Mass Challenge, Hinda L. and Arthur Marcus Foundation, The Loker Pinard Fund for Kidney Cancer Research at Dana-Farber Cancer Institute, National Institutes of Health, Conquer Cancer Foundation/Sontag Foundation, the release stated.



from Health News Today on Fox News https://ift.tt/Vu0m6rD
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • Tirzepatide drug fast-tracked for weight loss indication by FDA: What to know about itTirzepatide, an injection medication already approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes, is likely to receive FDA app… Read More
  • Employer-sponsored health insurance is not adequately covering all health services for many: reportMany Americans, particularly women, are having difficulty paying for their required health care services — especially dental and mental health care ne… Read More
  • European Union offers China free COVID vaccines as cases surgeThe European Union has offered free COVID-19 vaccines to China, the EU executive said on Tuesday, as infections there surged following Beijing's relax… Read More
  • Patients flood Shanghai hospitals after China relaxes its COVID policiesHospital beds were filled and long queues formed at hospitals in Shanghai on Tuesday, as China is urged to share its data on the latest COVID wave spr… Read More
  • Migrants crossing the southern border show signs of 'worsening trauma,' including sexual assault: reportEver since he began volunteering two months ago for weekend shifts at a clinic in one of the largest shelters in the border city of Ciudad Juarez, Mex… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • June 2025 (19)
  • May 2025 (88)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...
  • Carbon monoxide deaths are climbing, putting families in peril: ‘My son is lucky to be alive’
    Often dubbed "the silent killer," carbon monoxide is colorless and odorless — it’s been shown to cause severe injury or death in h...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates